These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


365 related items for PubMed ID: 31277685

  • 1. Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells.
    Han D, Yu T, Dong N, Wang B, Sun F, Jiang D.
    J Exp Clin Cancer Res; 2019 Jul 05; 38(1):289. PubMed ID: 31277685
    [Abstract] [Full Text] [Related]

  • 2. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.
    Zhang Y, Jin Z, Zhou H, Ou X, Xu Y, Li H, Liu C, Li B.
    Cancer Med; 2016 Jun 05; 5(6):1251-8. PubMed ID: 26899963
    [Abstract] [Full Text] [Related]

  • 3. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor.
    Hubbard JM, Grothey A.
    Drugs; 2017 Jul 05; 77(10):1091-1103. PubMed ID: 28573435
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo.
    Thulin MH, Määttä J, Linder A, Sterbova S, Ohlsson C, Damber JE, Widmark A, Persson E.
    Prostate; 2021 Jun 05; 81(8):452-462. PubMed ID: 33822400
    [Abstract] [Full Text] [Related]

  • 5. STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells.
    Liu Y, Peng X, Li H, Jiao W, Peng X, Shao J, Xu Y, Wang R, Wang W, Kong D.
    Recent Pat Anticancer Drug Discov; 2021 Jun 05; 16(3):350-362. PubMed ID: 33655847
    [Abstract] [Full Text] [Related]

  • 6. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone.
    Shao Z, Wang H, Ren H, Sun Y, Chen X.
    Molecules; 2023 Jul 27; 28(15):. PubMed ID: 37570646
    [Abstract] [Full Text] [Related]

  • 7. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
    Li Z, Chen Y, An T, Liu P, Zhu J, Yang H, Zhang W, Dong T, Jiang J, Zhang Y, Jiang M, Yang X.
    J Exp Clin Cancer Res; 2019 Mar 29; 38(1):139. PubMed ID: 30922391
    [Abstract] [Full Text] [Related]

  • 8. Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.
    Liu X, Huang J, Xie Y, Zhou Y, Wang R, Lou J.
    Med Sci Monit; 2019 Nov 24; 25():8905-8912. PubMed ID: 31760402
    [Abstract] [Full Text] [Related]

  • 9. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.
    Bi S, Chen K, Feng L, Fu G, Yang Q, Deng M, Zhao H, Li Z, Yu L, Fang Z, Xu B.
    Eur J Pharmacol; 2019 Jul 15; 855():252-261. PubMed ID: 31085238
    [Abstract] [Full Text] [Related]

  • 10. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway.
    Sai K, Wang S, Balasubramaniyan V, Conrad C, Lang FF, Aldape K, Szymanski S, Fokt I, Dasgupta A, Madden T, Guan S, Chen Z, Alfred Yung WK, Priebe W, Colman H.
    J Neurooncol; 2012 May 15; 107(3):487-501. PubMed ID: 22249692
    [Abstract] [Full Text] [Related]

  • 11. Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma.
    Li X, Wei Y, Wei X.
    Cancer Lett; 2020 Oct 28; 491():146-161. PubMed ID: 32798587
    [Abstract] [Full Text] [Related]

  • 12. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.
    Löcken H, Clamor C, Müller K.
    J Nat Prod; 2018 Jul 27; 81(7):1636-1644. PubMed ID: 30003778
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
    Zang J, Zheng MH, Cao XL, Zhang YZ, Zhang YF, Gao XY, Cao Y, Shi M, Han H, Liang L.
    Cell Commun Signal; 2020 Aug 26; 18(1):135. PubMed ID: 32843056
    [Abstract] [Full Text] [Related]

  • 14. Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial.
    Jonker DJ, Nott L, Yoshino T, Gill S, Shapiro J, Ohtsu A, Zalcberg J, Vickers MM, Wei AC, Gao Y, Tebbutt NC, Markman B, Price T, Esaki T, Koski S, Hitron M, Li W, Li Y, Magoski NM, Li CJ, Simes J, Tu D, O'Callaghan CJ.
    Lancet Gastroenterol Hepatol; 2018 Apr 26; 3(4):263-270. PubMed ID: 29397354
    [Abstract] [Full Text] [Related]

  • 15. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties.
    Mokgautsi N, Wen YT, Lawal B, Khedkar H, Sumitra MR, Wu ATH, Huang HS.
    Int J Mol Sci; 2021 Feb 28; 22(5):. PubMed ID: 33671112
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells.
    Zuo D, Shogren KL, Zang J, Jewison DE, Waletzki BE, Miller AL, Okuno SH, Cai Z, Yaszemski MJ, Maran A.
    J Exp Clin Cancer Res; 2018 Oct 04; 37(1):244. PubMed ID: 30286779
    [Abstract] [Full Text] [Related]

  • 17. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S, Das SK, Pradhan AK, Emdad L, Shen XN, Windle JJ, Sarkar D, Fisher PB.
    Oncotarget; 2016 Aug 23; 7(34):54102-54119. PubMed ID: 27472461
    [Abstract] [Full Text] [Related]

  • 18. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC, Chang WC, Hsu TI, Liu JJ, Yeh SH, Wang JY, Liou JP, Ko CY, Chang KY, Chuang JY.
    J Biomed Sci; 2016 Nov 18; 23(1):81. PubMed ID: 27863490
    [Abstract] [Full Text] [Related]

  • 19. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells.
    Wu N, Liu J, Zhao X, Yan Z, Jiang B, Wang L, Cao S, Shi D, Lin X.
    Tumour Biol; 2015 Dec 18; 36(12):9667-76. PubMed ID: 26150336
    [Abstract] [Full Text] [Related]

  • 20. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    Chang CH, Liu WT, Hung HC, Gean CY, Tsai HM, Su CL, Gean PW.
    BMC Cancer; 2017 Dec 29; 17(1):905. PubMed ID: 29284440
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.